{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:06:06Z","timestamp":1740107166756,"version":"3.37.3"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03042-9","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T16:01:36Z","timestamp":1715443296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bidirectional association between alopecia areata and prurigo nodularis: a population-based cohort study using TriNetX"],"prefix":"10.1007","volume":"316","author":[{"given":"David","family":"Garate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2951-6225","authenticated-orcid":false,"given":"Christopher J.","family":"Thang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4720-9229","authenticated-orcid":false,"given":"Jenny","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0261-0227","authenticated-orcid":false,"given":"Alyssa","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4609-2767","authenticated-orcid":false,"given":"George","family":"Golovko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1914-4077","authenticated-orcid":false,"given":"Michael G.","family":"Wilkerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5467-4102","authenticated-orcid":false,"given":"John S.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"issue":"4","key":"3042_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/all.15561","volume":"78","author":"Y Renert-Yuval","year":"2023","unstructured":"Renert-Yuval Y, Pavel AB, Del Duca E et al (2023) Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata. Allergy 78(4):1047\u20131059. https:\/\/doi.org\/10.1111\/all.15561","journal-title":"Allergy"},{"issue":"1","key":"3042_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jaci.2023.07.005","volume":"153","author":"F Ma","year":"2024","unstructured":"Ma F, Gharaee-Kermani M, Tsoi LC et al (2024) Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab. J Allergy Clin Immunol 153(1):146\u2013160. https:\/\/doi.org\/10.1016\/j.jaci.2023.07.005","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"3042_CR3","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41591-023-02320-9","volume":"29","author":"G Yosipovitch","year":"2023","unstructured":"Yosipovitch G, Mollanazar N, St\u00e4nder S et al (2023) Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials. Nat Med 29(5):1180\u20131190. https:\/\/doi.org\/10.1038\/s41591-023-02320-9","journal-title":"Nat Med"},{"issue":"5","key":"3042_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4103\/ijt.ijt_67_20","volume":"12","author":"J Lavian","year":"2020","unstructured":"Lavian J, Li SJ, Lee EY et al (2020) Validation of case identification for alopecia areata using International Classification of Diseases Coding. Int J Trichol 12(5):234. https:\/\/doi.org\/10.4103\/ijt.ijt_67_20","journal-title":"Int J Trichol"},{"issue":"2","key":"3042_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jaad.2021.10.026","volume":"87","author":"YS Roh","year":"2022","unstructured":"Roh YS, Marani M, Choi U et al (2022) Validation of International Classification of Diseases Tenth Revision code for Prurigo nodularis. J Am Acad Dermatol 87(2):482\u2013484. https:\/\/doi.org\/10.1016\/j.jaad.2021.10.026","journal-title":"J Am Acad Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03042-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03042-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03042-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T09:49:30Z","timestamp":1717494570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03042-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":5,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["3042"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03042-9","relation":{},"ISSN":["1432-069X"],"issn-type":[{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2024,5,11]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"John S. Barbieri has received consulting fees from Dexcel Pharma for work unrelated to the current submission. The authors have no other conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}],"article-number":"157"}}